HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jicheng Yang Selected Research

interleukin-24 (ST16)

1/2019Cationic Antheraea pernyi Silk Fibroin-Modified Adenovirus-Mediated ING4 and IL-24 Dual Gene Coexpression Vector Suppresses the Growth of Hepatoma Carcinoma Cells.
9/2015Antitumor effect and underlying mechanism of RGD-modified adenovirus mediated IL-24 expression on myeloid leukemia cells.
5/2015Prokaryotically and eukaryotically expressed interleukin-24 induces breast cancer growth suppression via activation of apoptosis and inhibition of tumor angiogenesis.
11/2014[Adenovirus-mediated interleukin-24 enhances the inhibitory effect of paclitaxel on the growth of lung cancer A549 cells].
2/2014Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
11/2013Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
9/2013Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
12/2011Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
2/2010The in vitro and in vivo antitumor activity of adenovirus-mediated interleukin-24 expression for laryngocarcinoma.
1/2010Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jicheng Yang Research Topics

Disease

36Neoplasms (Cancer)
01/2021 - 04/2006
7Melanoma (Melanoma, Malignant)
02/2014 - 08/2008
4Glioma (Gliomas)
04/2020 - 02/2010
4Hepatocellular Carcinoma (Hepatoma)
07/2019 - 07/2010
4Carcinoma (Carcinomatosis)
01/2019 - 06/2008
4Breast Neoplasms (Breast Cancer)
01/2016 - 08/2010
3Osteosarcoma (Osteogenic Sarcoma)
10/2015 - 10/2009
3Nasopharyngeal Carcinoma
03/2015 - 09/2013
3Stomach Neoplasms (Stomach Cancer)
11/2013 - 10/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2012 - 08/2008
2Infections
10/2022 - 11/2014
2Laryngeal Neoplasms (Laryngeal Cancer)
01/2022 - 02/2010
2Wounds and Injuries (Trauma)
01/2019 - 02/2009
2Lung Neoplasms (Lung Cancer)
11/2014 - 06/2008
2Colonic Neoplasms (Colon Cancer)
01/2011 - 09/2009
1Fibrosarcoma
01/2021
1Adenoviridae Infections (Adenovirus Infections)
04/2020
1Liver Neoplasms (Liver Cancer)
07/2019
1Myeloid Leukemia (Leukemia, Myelocytic)
09/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2015
1Cancer Pain
10/2013
1Adenocarcinoma of Lung
01/2011

Drug/Important Bio-Agent (IBA)

12interleukin-24 (ST16)IBA
01/2019 - 06/2008
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 06/2006
10Therapeutic UsesIBA
10/2015 - 08/2007
9Caspase 3 (Caspase-3)IBA
01/2016 - 10/2009
8Proteins (Proteins, Gene)FDA Link
10/2015 - 06/2008
8CytokinesIBA
09/2015 - 06/2008
5InterleukinsIBA
10/2013 - 02/2007
5Interleukin-6 (Interleukin 6)IBA
10/2013 - 06/2008
5Interleukin-8 (Interleukin 8)IBA
12/2011 - 11/2008
4SurvivinIBA
01/2022 - 10/2012
3Fibroins (Fibroin)IBA
07/2019 - 02/2009
2Caspase 9IBA
01/2016 - 08/2010
2Interleukin-10 (Interleukin 10)IBA
09/2015 - 10/2013
2VaccinesIBA
09/2015 - 04/2006
2Cytochromes c (Cytochrome c)IBA
12/2011 - 08/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 06/2008
2Amino AcidsFDA Link
04/2009 - 11/2008
1Attenuated VaccinesIBA
10/2022
1Biological ProductsIBA
01/2022
1aziridine (ethyleneimine)IBA
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1Arginine (L-Arginine)FDA Link
04/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
04/2020
1Aspartic Acid (Aspartate)FDA Link
04/2020
1adenovirus receptorIBA
04/2020
1Peptides (Polypeptides)IBA
07/2019
1IntegrinsIBA
01/2019
1arginyl-glycyl-aspartic acidIBA
01/2019
1PolymersIBA
01/2019
1CollagenIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
05/2015
1Paclitaxel (Taxol)FDA LinkGeneric
11/2014
1Cyclin D1IBA
02/2014
1Cisplatin (Platino)FDA LinkGeneric
11/2013
1Small Interfering RNA (siRNA)IBA
10/2013
1EndorphinsIBA
10/2013
1Beclin-1IBA
07/2013
1CaspasesIBA
07/2013
1Matrix Metalloproteinases (MMPs)IBA
12/2011
1Caspase 8 (Caspase-8)IBA
12/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2011
1thiazolyl blueIBA
01/2011
1Pharmaceutical PreparationsIBA
01/2011
1Interleukin-17 (Interleukin 17)IBA
07/2010
1Catalytic RNA (Ribozymes)IBA
09/2009
1hairpin ribozymeIBA
09/2009
1Green Fluorescent ProteinsIBA
04/2009
1Biocompatible Materials (Biomaterials)IBA
02/2009
1Interferon-gamma (Interferon, gamma)IBA
06/2008
1PerforinIBA
08/2007

Therapy/Procedure

11Therapeutics
07/2019 - 08/2007
8Injections
10/2015 - 06/2006
2Radiotherapy
09/2013 - 03/2012
1Transplantation
04/2020
1Drug Therapy (Chemotherapy)
11/2013
1Immunotherapy
08/2007
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2007